Literature DB >> 10889284

Estrogen affects cognition in women with psychosis.

K Thompson1, A Sergejew, J Kulkarni.   

Abstract

Estrogen has been reported to affect aspects of cognition and psychopathology in women, both normal and with psychosis. This study aimed to replicate and extend this research by investigating the effect of estrogen on cognition over the menstrual cycle in a group of normal women and women with psychosis. The sample consisted of 31 premenstrual normal control subjects, and 29 women with psychosis. Subjects were tested twice, 2 weeks apart on a number of cognitive tests. There was no difference in Positive and Negative Symptom Scale scores between the follicular and luteal phases of the menstrual cycle. Both groups of women performed better on the Revised Mental Rotation Test and Trails A during the follicular phase when estrogen levels were low. Contrary to expectation, during the luteal phase, when estrogen was high, the control subjects showed no significant improvement in performance on verbal articulatory-motor tasks, and the women with psychosis performed significantly worse on the Purdue Pegboard. The unexpected adverse effect of high levels of estrogen on motor performance in the psychotic women was hypothesized to be related to their disease process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889284     DOI: 10.1016/s0165-1781(00)00161-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia.

Authors:  Leah H Rubin; Gretchen L Haas; Matcheri S Keshavan; John A Sweeney; Pauline M Maki
Journal:  Neuropsychopharmacology       Date:  2007-03-28       Impact factor: 7.853

2.  Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2015-05-16       Impact factor: 4.939

3.  Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2010-10-13       Impact factor: 4.939

Review 4.  Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies.

Authors:  Louise Nora Nolan; Liz Hughes
Journal:  Arch Womens Ment Health       Date:  2022-07-22       Impact factor: 4.405

5.  Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.

Authors:  Niels Bergemann; Peter Parzer; Susanne Jaggy; Beatrice Auler; Christoph Mundt; Sabine Maier-Braunleder
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

6.  Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.

Authors:  J Kulkarni; E Gavrilidis; W Wang; R Worsley; P B Fitzgerald; C Gurvich; T Van Rheenen; M Berk; H Burger
Journal:  Mol Psychiatry       Date:  2014-04-15       Impact factor: 15.992

7.  Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis.

Authors:  Thomas J Reilly; Vanessa C Sagnay de la Bastida; Dan W Joyce; Alexis E Cullen; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

8.  A computational lens on menopause-associated psychosis.

Authors:  Victoria L Fisher; Liara S Ortiz; Albert R Powers
Journal:  Front Psychiatry       Date:  2022-08-03       Impact factor: 5.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.